The insulin-like growth factor system in bone: basic and clinical implications.
about
Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implicationsBone metabolism in children and adolescents: main characteristics of the determinants of peak bone massLong-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy.Aerobic glycolysis in osteoblasts.Gene signature of the embryonic meniscus.Hedgehog signaling activates a positive feedback mechanism involving insulin-like growth factors to induce osteoblast differentiation.Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.Interaction of the endocrine system with inflammation: a function of energy and volume regulation.Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation.E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.Hepatitis C virus infection and risk of osteoporosis: A meta-analysis.Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis.Human annulus cells regulate PAPP-A and IGFBP-4 expression, and thereby insulin-like growth factor bioavailability, in response to proinflammatory cytokine exposure in vitro.Effects of insulin-like growth factor-1 on random pattern skin flap survival in rats.Imaging IGF-I uptake in growth plate cartilage using in vivo multiphoton microscopy.Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.Bone metabolism in adolescent girls with eating disorders and weight loss: independent effects of weight change, insulin-like growth factor-1 and oestradiol.Sexual Dimorphism and the Origins of Human Spinal Health.Hepatitis C virus infection and risk of osteoporotic fracture: A systematic review and meta-analysis.Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
P2860
Q26824690-F1A62B1F-E712-4560-BC07-E367ED5B8FA5Q26996397-6D52E0B2-DC4E-4931-BAE1-5BFA2AE24CB3Q34046986-E7EF9338-37B2-427E-ADA2-708AA0CB592AQ34437563-8593F2D4-636F-49A6-9AC4-687751B53501Q35012865-856B2585-69C9-446A-8B36-9A2726451EFAQ35485124-F073AF49-516C-432A-840E-7538F9B9DA53Q36579281-984B94A9-EF6B-474B-9014-99B029A2B41DQ37690138-03F73695-6221-4F10-9D65-E6033D8682A2Q37736766-73FEF165-CAC5-4F4C-9048-722443BFCD48Q38074797-857D386A-DE23-4559-90EE-49E0929F4A18Q38285398-22153D6A-9E86-47FA-907F-E11AEE43F80BQ38672659-3561D24E-A126-4BA0-8335-214525CE3915Q38944284-A8F4BED2-551C-4670-B02D-9A6313BDDBEAQ39345876-C0500CA2-981C-4CE5-A1C8-A9C15790E5D1Q39436416-717B2665-3C9C-49DC-8A37-9CAA7A26145DQ45065150-F2D368CF-7DBE-4159-92AC-7212DA585FEDQ47252219-FFC45458-DB4A-406E-9FD0-A2BCDD9E2B33Q47439858-3BF147A6-83BE-44EA-8564-A5EAF0964744Q47547799-D5E5D6CB-43B3-40D2-A1CF-48BF9ED17722Q47555545-DDF0F478-B765-42C3-B507-D0AA5AC21987Q48730139-A96FABA1-1387-438B-9D94-56EE463F2AE2
P2860
The insulin-like growth factor system in bone: basic and clinical implications.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The insulin-like growth factor system in bone: basic and clinical implications.
@ast
The insulin-like growth factor system in bone: basic and clinical implications.
@en
type
label
The insulin-like growth factor system in bone: basic and clinical implications.
@ast
The insulin-like growth factor system in bone: basic and clinical implications.
@en
prefLabel
The insulin-like growth factor system in bone: basic and clinical implications.
@ast
The insulin-like growth factor system in bone: basic and clinical implications.
@en
P2860
P1476
The insulin-like growth factor system in bone: basic and clinical implications.
@en
P2093
Clifford J Rosen
Masanobu Kawai
P2860
P304
323-33, vi
P356
10.1016/J.ECL.2012.04.013
P577
2012-05-15T00:00:00Z